In the Covid-19 program, VacciZone is designing a specific variant of ASC speck carrying antigens coming from the Spike protein of SARS-CoV2. We have demonstrated that our fusion protein can form a functional speck structure. The purified specks have been injected into the BALB/C mice. The collected sera from immunized mice showed that the Vaccizone Covid-19 vaccine stimulates the expected immune response against SARS-CoV2. Phase-I studies are expected to start soon.

In the veterinary vaccines program, VacciZone is utilizing ASC Speck technology to create powerful purely protein-based alternatives to existing veterinary vaccines resistant to harsh weather conditions.